{
    "symbol": "THC",
    "quarter": 1,
    "year": 2022,
    "date": "2022-04-21 13:52:02",
    "content": " Also their adjusted EBITDA of $92 million represented 7% growth over the first quarter last year, and Conifer continued to produce so strong EBITDA margin of 28.4%. Please proceed with your question. Please proceed with your question. Please proceed with your question. I'm sorry, just real quick, a little bit more color on USPI, as Saum and Dan mentioned, we were obviously very pleased to see 8% year-over-year growth in our cases, especially considering we had one of the highest cancellation rates we've ever seen at 22.8% in January and overall cancellation rated 19.3% in the quarter compared to 17.8% in Q1 of 2021. Please proceed with your question. Hey, good morning guys. Please proceed with your question. Hey, good morning guys. Please proceed with your question. Please proceed with your question. Please proceed with your question. But one thing, to keep in mind, we did have some of that money in last year's first quarter as well, but so how I would think about it is probably, we've been talking about in terms of our revenue growth on a per adjusted mission basis is, probably, 3% type of area and driven by our managed care contracting strategy as well as our focus on higher acuity service lines. Please proceed with your question. Please proceed with your question. Hey, good morning guys. Please proceed with your question. Please proceed with your question. Please proceed with your question. Please proceed with your question."
}